A beneficial levels of 25-hydroxyvitamin D for a decrease in thyrotropin receptor antibody (TRAB) in patients with Graves’ disease: a real-world study
Abstract Objective This study aimed to determine whether a relationship exist between pre-therapy 25-hydroxyvitamin D levels and the remission/negative conversion rates of thyrotropin receptor antibody (TRAB) during treatment in patients with newly diagnosed Graves’ disease (GD). Methods 171 patient...
Saved in:
Main Authors: | Xide Chen, Yongze Zhang, Luxi Lin, Yuxia Chen, Ximei Shen, Lingning Huang, Fengying Zhao, Sunjie Yan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Endocrine Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12902-024-01823-x |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Combined 25-hydroxyvitamin D concentrations and physical activity on mortality in US stroke survivors: findings from the NHANES
by: Junqi Liao, et al.
Published: (2025-01-01) -
The Relationship Between Novel Inflammatory Markers and Serum 25‐Hydroxyvitamin D Among US Adults
by: Hang Zhao, et al.
Published: (2025-01-01) -
Genetic and Plasma Proteomic Approaches to Identify Therapeutic Targets for Graves’ Disease and Graves’ Ophthalmopathy
by: Ke C, et al.
Published: (2025-02-01) -
Incidence and risk factors for Graves’ orbitopathy in patients who underwent anti-inflammatory and immunosuppressive treatment during medical treatment for Graves’ disease: investigation of 1,553 cases with newly diagnosed Graves’ disease and proposal of a predictive score
by: Natsuko Watanabe, et al.
Published: (2023-11-01) -
Study on the correlation between serum IgG4/IgG levels and the development of Graves’ ophthalmopathy
by: Yuanyuan Deng, et al.
Published: (2025-01-01)